SOUTH SAN FRANCISCO, Calif., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that executive management will participate in the 11th Annual BIO CEO & Investor Conference to be held February 9 through February 10, 2009 at the Waldorf-Astoria in New York City. Steven R. Deitcher, M.D., President and Chief Executive Officer, is scheduled to present an overview of the company and its pipeline programs at 9:00 a.m. ET on Tuesday, February 10, 2009.
